In the News

• December 2010

  RoundTable Healthcare Partners Portfolio Company, Renaissance Pharma, Acquires Confab Laboratories

  LAKE FOREST, IL, December 21, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Renaissance Pharma Inc. (“Renaissance”), has acquired Confab Laboratories Inc. (“Confab”). Confab is a leading contract pharmaceutical manufacturer in St. Hubert, located on the south shore of Montreal, Québec, Canada.

  more

• December 2010

  Renaissance Pharma, compagnie associée de RoundTable Healthcare Partners, fait l’acquisition de Laboratoires Confab Inc.

  LAKE FOREST, Illinois, le 21 décembre 2010 /PRNewswire/ — RoundTable Healthcare Partners (« RoundTable »), une entreprise privée d’investissement à vocation opérationnelle dont les activités sont dédiées au secteur des soins de santé, a annoncé aujourd’hui qu’une de leur compagnie associée, Renaissance Pharma Inc. (« Renaissance »), a fait l’acquisition de Laboratoires Confab Inc. (« Confab »). Confab est une entreprise de fabrication à façon de premier plan dans le domaine pharmaceutique, située sur la Rive-Sud de Montréal.

  more

• December 2010

  RoundTable Healthcare Partners Announces Sale of Clinical Innovations, LLC to The Pritzker Group

  LAKE FOREST, IL, December 15, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has entered into a definitive agreement to sell one of its portfolio companies, Clinical Innovations, LLC (“Clinical”), to The Pritzker Group, a private investment firm representing Pritzker family interests. Terms of the transaction were not disclosed.

  more

• November 2010

  RoundTable Healthcare Partners Acquires Majority Stake in Salter Labs

  LAKE FOREST, IL, November 2, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has acquired a majority interest in Salter Labs (“Salter”). Founded in 1976 by Peter Salter, Salter is a leading manufacturer of disposable respiratory and sleep diagnostics products used in both the home medical and acute care markets.

  more

• December 2010

  Tribute to Bob DeBaun: At the end of 2010, our dear friend, mentor and colleague, Bob DeBaun, passed away. He will forever be in our hearts.

  At the end of 2010, our dear friend, mentor and colleague, Bob DeBaun, passed away. He will forever be in our hearts.

  more

• October 2010

  RoundTable Healthcare Partners Portfolio Company, Argon Medical Devices, Inc., Acquires Critical Care and Extended Dwell Catheter Product Platforms from BD

  LAKE FOREST, IL, October 4, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that its portfolio company, Argon Medical Devices, Inc. (“Argon”), has acquired the critical care and extended dwell catheter product platforms consisting of blood pressure monitoring devices, and central venous, pulmonary artery and extended dwell catheters from BD (Becton, Dickinson and Company). Argon is a global manufacturer and marketer of single-use specialty medical devices for procedures in Interventional Radiology, Interventional Cardiology, and Critical Care.

  more

• March 2010

  Argon Medical Devices Announces Exclusive License and distribution agreement for Option™ Retrievable Inferior Vena Cava Filter

  ATHENS, TX, March 8, 2011 – Argon Medical Devices, Inc. announced today that it has entered into a definitive license agreement with Rex Medical, LP(“Rex Medical”) for exclusive global rights to market and distribute the Option™ Retrievable Vena Cava Filter, an implantable device used in the prevention of Pulmonary Embolism (PE).

  more

• August 2010

  RoundTable Healthcare Partners Establishes New Ophthalmology Platform

  LAKE FOREST, IL, August 2, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc. (“Beaver-Visitec”), consists of ophthalmology products and assets recently acquired from BD (Becton, Dickinson and Company) and Medtronic, Inc.

  more

• August 2010

  RoundTable Healthcare Partners Portfolio Company, Aspen Surgical Products, Inc., Acquires Bard-ParkerTM Surgical Blades and Scalpels Business

  LAKE FOREST, IL, August 2, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Aspen Surgical Products, Inc. (“Aspen”), has acquired the Bard-ParkerTM surgical blades and scalpels business from BD (Becton, Dickinson and Company). Aspen is a leading manufacturer of disposable medical products with an emphasis on the operating room environment and safety.

  more

• July 2010

  RoundTable Healthcare Partners Closes Two Funds

  LAKE FOREST, IL, July 15, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today the closing of its third equity fund totaling $600 million (“Fund III”) and its second captive subordinated debt fund of $200 million (“Capital Fund II”). RoundTable closed its first equity fund of $400 million in March 2002 and its second equity fund of $500 million in March of 2005. The first capital fund of $200 million was closed in July of 2006.

  more

• July 2010

  RoundTable Healthcare Partners Announce Sale of Bioniche Pharma Holdings Limited to Mylan Inc.

  LAKE FOREST, IL, July 14, 2010 — RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that it has entered into a definitive agreement to sell one of its portfolio companies, Bioniche Pharma Holdings Limited (“Bioniche Pharma”) to Mylan Inc. (“Mylan”), a leading, global generic and specialty pharmaceutical company, for $550 million in cash. The closing is conditional on regulatory approval and other customary closing conditions.

  more

• June 2010

  RoundTable Healthcare Partners Makes Investment in Aqua Pharmaceuticals, LLC

  LAKE FOREST, IL, June 23, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has made a controlling investment in Aqua Pharmaceuticals, LLC . (“Aqua”). Founded in 2004, Aqua is a specialty dermatology pharmaceutical company focused on acquiring, developing and marketing under-promoted, branded, pharmaceutical products in the United States. Financial terms of the transaction were not disclosed.

  more

• June 2010

  RoundTable Healthcare Partners Enters Into Agreement with BD to Acquire Ophthalmic Systems Unit

  LAKE FOREST, IL, June 8, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that is has entered into an agreement with BD (Becton, Dickinson and Company) to acquire the Ophthalmic Systems unit, a business within the BD Medical segment. BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The transaction is expected to be completed by September 30, 2010 subject to customary closing conditions, including consultations and regulatory approvals. Financial terms of the agreements were not disclosed.

  more

• June 2010

  RoundTable Healthcare Partners and Argon Medical Devices Announce Definitive Agreement with BD

  LAKE FOREST, IL, June 8, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that its portfolio company, Argon Medical Devices, Inc. (“Argon”), entered into an agreement with BD (Becton, Dickinson and Company) for BD’s critical care systems product platform consisting of blood pressure monitoring devices, and central venous, pulmonary artery and extended dwell catheters. BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems, and reagents.

  more

• June 2010

  RoundTable Healthcare Partners and Aspen Surgical Products Announce Definitive Agreement with BD

  LAKE FOREST, IL, June 8, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the health-care industry, announced today that its portfolio company, Aspen Surgical Products, Inc. (“Aspen”) has entered into an agreement with BD (Becton, Dickinson and Company) to acquire the Bard-ParkerTM surgical blades and scalpels business. BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems, and reagents.

  more

• May 2010

  RoundTable Healthcare Partners Announce Partnership with Pierre Frechette to form Renaissance Pharma Inc.

  LAKE FOREST, IL, May 25, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it will be partnering with Pierre Fréchette to form Renaissance Pharma Inc. (“Renaissance Pharma”). The new company, headquartered on the south shore of Montreal, will focus on identifying and building new pharmaceutical platforms. RoundTable has committed to support Renaissance Pharma with the full resources of the firm including substantial investment capital.

  more

• May 2010

  RoundTable Healthcare Partners Announce Partnership with Pierre Frechette to form Renaissance Pharma Inc. (French Version)

  LAKE FOREST, Illinois, 19 mai /PRNewswire/ — RoundTable Healthcare Partners (« RoundTable »), une entreprise privée d’investissements à vocation opérationnelle dont les activités sont concentrées exclusivement dans le secteur des soins de santé, a annoncé aujourd’hui qu’elle va s’associer à M. Pierre Frechette pour former Renaissance Pharma Inc. (« Renaissance Pharma »). La nouvelle société, basée sur la rive sud de Montréal, se concentrera sur l’identification et la gestion de nouvelles plates-formes pharmaceutiques. RoundTable est déterminée à soutenir Renaissance Pharma au moyen de toutes les ressources de la société notamment grâce à d’importants capitaux de placement.

  more

• March 2010

  RoundTable Healthcare Partners Names Charles W. Stiefel as Senior Advisor

  LAKE FOREST, IL, March 4, 2010 — RoundTable Healthcare Partners (“RoundTable”), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that Charles W. Stiefel has joined the firm as Senior Advisor. In this capacity, Mr. Stiefel will assist RoundTable in identifying investment opportunities, facilitating key industry introductions, and advising the firm on strategic and operational issues.

  more